Working with endurance racehorses, researchers are helping detect a new, easy-to-use technique for detecting heart disease in horses. Supplied photo.

The race to develop a better equine heart disease detection tool

University of Saskatchewan (USask) researchers are teaming up with local and national endurance racing competitors to develop a new, easy-to-use technique for early detection of cardiac disease in performance horses.

By Jon Morton

Jon Morton is featured in WCVM Next Gen Scientists. This mini podcast series explores the diverse research and experiences of University of Saskatchewan students based at the WCVM. Listen here.


 

Cardiovascular disease is less common in horses than in people, but unmanaged heart disease is one of the leading causes of sudden death in athletic horses during exercise. Sudden athletic death accounts for one to three deaths per 10,000 starts in equestrian events, with 25 per cent of these sudden deaths being related directly to underlying heart disease.

While heart disease poses an obvious threat to equine athletes, it can also place riders’ safety in jeopardy since most equine deaths occur during exercise, with one in four riders reporting injuries to their arms and legs.

The challenge is that clinical signs of heart disease in horses are “vague and non-specific,” says Dr. Vanessa Cowan (DVM, PhD), a veterinary toxicologist at the Western College of Veterinary Medicine (WCVM). Tiring easily, difficulty breathing and poor athletic performance are common symptoms of heart disease — but they could also indicate other health issues in horses. 

As Cowan explains, most western Canadian large animal veterinarians don’t have access to diagnostic equipment that can specifically detect damage to heart muscle in equine patients. Instead, they must rely on traditional techniques such as echocardiography and electrocardiograms (ECGs).

While these techniques are invaluable for detecting heart disease, they require additional training to use, says Cowan. And since there are few equine cardiac specialists in Western Canada, there’s a need for easy-to-interpret diagnostic tools.

To help veterinarians detect heart muscle damage more quickly both in the clinic and out in the field, Cowan is leading a research project that aims to validate a human-based test kit called I-STAT1 for use in horses.

Human physicians use the I-STAT1 test kit to rapidly detect cardiac troponin, which is released with cardiac muscle damage such as a heart attack, says Cowan: “The benefit of the I-STAT1 is that you get test results much quicker than you would in a lab setting — [in] about 10 minutes.”

The rapid detection of troponin allows for the use of this machine in emergencies and field research, “especially in the case of endurance racing where we can be several hours away from the WCVM Veterinary Medical Centre,” explains Cowan.

Additionally, the device is very accessible for providers as it’s easy to interpret the results and only requires a “small portion of blood,” says Cowan.
Jon Morton is a University of Saskatchewan master's student based in the WCVM Department of Veterinary Biomedical Sciences. Photo: Cat Zens.

The WCVM researchers aim to evaluate this device’s use in horses by working with local endurance race competitors during their races. Endurance racing is an equine performance sport that demands a lot from a horse’s cardiovascular system and requires extensive training, says Cowan.

Through the team’s work, they will evaluate if the I-STAT1 test kit can accurately detect and measure equine cardiac troponin while also serving as an indicator of how much cardiac strain occurs during endurance races.

The term “sudden athletic death” describes any death up to three days following an intensive athletic event like an endurance race. Since horses with mild clinical signs can deteriorate quickly during this short period, it’s critical to underscore the importance of accurate, rapid diagnostics that can be performed in the field and in a veterinary clinic.

Investigating how troponin is released during endurance racing will allow practitioners to detect heart muscle damage and to track troponin levels over three days so they can intervene quickly in emergent situations.

The WCVM researchers plan to attend nine race events over two summer seasons, collecting blood samples and a one-minute ECG recordings (to detect arrhythmia) from each equine competitor at three points during each race. Then, team members will run the I-STAT1 test at each race site to determine the amount of troponin in the bloodstream before, during and after competition.

Researchers have already collected samples from 15 horses that participated in a 25-mile (40 kilometres or km) or a 50-mile (80 km) race during the 2025 race season.

Cowan’s research group now plans to enrol more horses this upcoming summer. Their goal is to include horses competing in the 75-mile (120-km) or 100-mile (160-km) races during the 2026 National Endurance Championship in August 2026. The Saskatchewan Long Riders Club is hosting the national event near Prince Albert, Sask.

Inclusion of these top equine athletes will help researchers determine if the strain on the equine heart differs with distance travelled and if each animal’s heart muscle suffers post-race damage.

Determining the amount of troponin in these horses at these points will allow researchers to compare the accuracy of the I-STAT1 using an equine-specific test. A high degree of accuracy between the two test kits would allow for the I-STAT1 to be “implemented in the WCVM Veterinary Medical Centre or even in the WCVM equine field service as a way to improve diagnostics for cardiac work-ups in horses,” says Cowan.

“Our hope is that we can use existing human-based test methods — rapid test methods — to learn more about equine athletes and patients,” says Cowan.

The Townsend Equine Health Research Fund (TEHRF) has provided financial support for this research project. Jon Morton of Winnipeg, Man., is a USask Master of Science (MSc) student based at the WCVM under the supervision of Dr. Vanessa Cowan.